Sodium Glucose Cotransporter-2 Inhibitors and Salt-sensitivity in Type 2 Diabetes

计划入组 30 人 · 首次发布于 2023 年 8 月 23 日

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

计划入组 10 人 · 首次发布于 2025 年 9 月 15 日

Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy

计划入组 18 人 · 首次发布于 2022 年 8 月 23 日

Sodium Lactate and Glucose

Rx

Glucose and Sodium Chloride Potassium Chloride

Rx

2-deoxy-2-fluoro-α-D-glucose

C₆H₁₁FO₅

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

FDA Advisory Committee to Review Sotagliflozin for Type 1 Diabetes and Chronic Kidney Disease

FDA Advisory Committee to Review Lexicon's Sotagliflozin for Type 1 Diabetes and CKD

SSY Group Receives Approval for Compound Sodium Acetate and Glucose Injection in China